According to the WSJ today PhRMA is spending $13.2 million in an “ad buy to prop up 28 Congressional candidates, many of them vulnerable and all but three of them Democrats.” The Journal points out
“Money follows power, and obviously the drug makers believe they need to reposition themselves politically with the prospect of a Democratic Congress and Barack Obama in the White House. Industry campaign donations skewed about 3-to-1 in favor of the GOP over the last six election cycles. Now they’re running about even, according to the Center for Responsive Politics. Some of the beneficiaries will play key roles in shaping legislation next year, such as Max Baucus, Chairman of Senate Finance, and Oregon Democrat Ron Wyden, a dominant voice on health policy.”